Nakajima; Suanne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nakajima; Suanne.The latest application filed is for "6-11 bridged oxime erythromycin derivatives".

Company Profile

0.11.17

Nakajima; Suanne - Winchester MA
Nakajima; Suanne - Cambridge MA
Nakajima; Suanne - Arlington MA
Nakajima, Suanne - Newark DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors Grant 8,236,807 - Nakajima , et al. August 7, 2	2012-08-07
Macrocyclic hepatitis C serine protease inhibitors Grant 8,124,584 - Miao , et al. February 28, 2	2012-02-28
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors Grant RE42,375 - Nakajima , et al. May 17, 2	2011-05-17
Tri-peptide hepatitis C serine protease inhibitors Grant 7,718,769 - Miao , et al. May 18, 2	2010-05-18
6-11 Bridged Oxime Erythromycin Derivatives App 20100041618 - Wang; Guoqiang ; et al.	2010-02-18
Quinoxalinyl Macrocyclic Hepatitis C Serine Protease Inhibitors App 20100015092 - Nakajima; Suanne ; et al.	2010-01-21
Macrocyclic Hepatitis C Serine Protease Inhibitors App 20090304629 - Miao; Zhenwei ; et al.	2009-12-10
Macrocyclic hepatitis C serine protease inhibitors Grant 7,601,709 - Miao , et al. October 13, 2	2009-10-13
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors Grant 7,566,719 - Nakajima , et al. July 28, 2	2009-07-28
6-11 Bridged Oxime Erythromycin Derivatives App 20080262208 - Wang; Guoqiang ; et al.	2008-10-23
Quinoxalinyl Macrocyclic Hepatitis C Serine Protease Inhibitors App 20080152622 - Nakajima; Suanne ; et al.	2008-06-26
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors Grant 7,368,452 - Nakajima , et al. May 6, 2	2008-05-06
Tri-peptide hepatitis C serine protease inhibitors Grant 7,273,851 - Miao , et al. September 25, 2	2007-09-25
Tri-peptide hepatitis C serine protease inhibitors App 20070161575 - Miao; Zhenwei ; et al.	2007-07-12
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors App 20070060510 - Nakajima; Suanne ; et al.	2007-03-15
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors Grant 7,176,208 - Nakajima , et al. February 13, 2	2007-02-13
Aza-peptide macrocyclic hepatitis c serine protease inhibitors App 20070021330 - Wu; Frank ; et al.	2007-01-25
6-11 Bridged oxime erythromycin derivatives App 20060252712 - Wang; Guoqiang ; et al.	2006-11-09
6-11 Bridged oxime erythromycin derivatives App 20060252710 - Wang; Guoqiang ; et al.	2006-11-09
Aza-peptide macrocyclic hepatitis C serine protease inhibitors Grant 7,125,845 - Wu , et al. October 24, 2	2006-10-24
Tri-peptide hepatitis C serine protease inhibitors App 20050261200 - Miao, Zhenwei ; et al.	2005-11-24
Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors Grant 6,951,872 - Jacobson , et al. October 4, 2	2005-10-04
Macrocyclic hepatitis C serine protease inhibitors App 20050153877 - Miao, Zhenwei ; et al.	2005-07-14
Aza-peptide macrocyclic hepatitis C serine protease inhibitors App 20050065073 - Wu, Frank X. H. ; et al.	2005-03-24
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors App 20040266668 - Nakajima, Suanne ; et al.	2004-12-30
Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors App 20040180815 - Nakajima, Suanne ; et al.	2004-09-16
Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors App 20040132718 - Jacobson, Irina C. ; et al.	2004-07-08
Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors App 20020183324 - Jacobson, Irina C. ; et al.	2002-12-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.